European Commission bolsters defences against critical medicine shortages
The EC announced new initiatives to tackle critical medicine shortages in winter, introducing more flexibility to strengthen supplies.
27 October 2023
27 October 2023
The EC announced new initiatives to tackle critical medicine shortages in winter, introducing more flexibility to strengthen supplies.
A pivotal Phase III trial will be initiated in the coming months to further evaluate the lead formulations of the combination vaccine.
Moderna's Senior Vice President of International Manufacturing discusses the impact of Covid-19 on mRNA applications and future trends in manufacturing.
Verily's molecular and real-world evidence offerings will be leveraged to develop Georgiamune's drug candidates.
The FDA did not originally approve the therapy earlier this year; it will now go undergo a second review.
In two Phase III trials, Vabysmo showed non-inferior visual acuity gains versus aflibercept at 24 weeks.
The treatment is delivered using an infusion pump that provides the drug over the course of 24 hours.
The approval is based on data from three pivotal studies: FLAIR, ATLAS and the Phase IIIb ATLAS-2M study.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Join us on November 1st as Cynthia Bheling, Zobair Younossi, Rohit Loompa, and Vipul Jairath provide an overview of the drug development landscape.
Give your business an edge with our leading industry insights.